Jayakrishna Ambati

Form D signer

Jayakrishna Ambati

President at Inflammasome Therapeutics

Form D signer

Capital raised by Inflammasome Therapeutics

$13.2M+$13.2M latest round

1 Form D filing · first filed Feb 2026 · Newton, MA

CURRENT ROLE: President
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: —

Career

1 company on file

Inflammasome TherapeuticsBiotech · Newton, MAsince Feb 2026

President

Signatory on Inflammasome Therapeutics's Form D filings · $13.2M raised across 1

Company filings

via EDGAR · Form D for Inflammasome Therapeutics1

DateCompanyFormAmountRole on filing

Feb 27, 2026Inflammasome TherapeuticsForm D+$13.2MPresident

Form DFeb 27, 2026 · Inflammasome Therapeutics+$13.2Mas President

Overview

Last filing Feb 27, 2026

Jayakrishna Ambati is on file as President at Inflammasome Therapeutics in Newton, MA. Inflammasome Therapeutics has 1 Form D filing on record, $13.2M raised in total. Jayakrishna Ambati appears as a signatory on the company's filings.

LinkedIn profile

Teammates

Inflammasome Therapeutics · 1

Babur LateefDirector

Products

Inflammasome Therapeutics · 1

K8 (Kamuvudine-8)Small-molecule therapeutic candidate

A first-in-class dual inflammasome inhibitor delivered as a sustained-release intraocular implant, in development for geographic atrophy, the advanced form of dry age-related macular degeneration.